These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2798459)

  • 1. Release of cysteinyl leukotrienes is of minor importance in platelet-activating factor-induced reduction of perfusion rate in the rat gastric vascular bed.
    Dembinska-Kiec A; Novak P; Peskar BM; Peskar BA
    Prog Clin Biol Res; 1989; 301():487-91. PubMed ID: 2798459
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed.
    Dembińska-Kieć A; Peskar BM; Peskar BA
    Biomed Biochim Acta; 1988; 47(10-11):S228-32. PubMed ID: 3248109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
    Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability.
    Hatakeyama K; Yano S; Watanabe K
    Scand J Gastroenterol Suppl; 1989; 162():71-4. PubMed ID: 2595312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration.
    Rainsford KD
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():209-15. PubMed ID: 3774846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    J Clin Invest; 1986 Jul; 78(1):108-14. PubMed ID: 3459734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cysteinyl leukotrienes in gastric mucosal damage in rats.
    Peskar BM
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():552-5. PubMed ID: 2546395
    [No Abstract]   [Full Text] [Related]  

  • 8. Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.
    Spencer DA; Evans JM; Green SE; Piper PJ; Costello JF
    Thorax; 1991 Jun; 46(6):441-5. PubMed ID: 1858084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the mechanism of endothelin-induced rat gastric mucosal lesion formation].
    Katoh N; Itoh M; Yokoyama Y; Joh T
    Nihon Shokakibyo Gakkai Zasshi; 1994 Jan; 91(1):27-35. PubMed ID: 8309086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock.
    Wallace JL; Hogaboam CM; McKnight GW
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G140-6. PubMed ID: 2372058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent effects of interleukin-1 on smooth muscle preparations from adrenalectomized rats: implications for increased phospholipase-A2 activity via stimulation of 5-lipoxygenase.
    Mugridge KG; Perretti M; Becherucci C; Parente L
    J Pharmacol Exp Ther; 1991 Jan; 256(1):29-37. PubMed ID: 1899119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach.
    Wallace JL; Cirino G; De Nucci G; McKnight W; MacNaughton WK
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G661-6. PubMed ID: 2650567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of PF-10040 in experimental NSAID-gastritis: role of leukocytes, leukotrienes and PAF.
    Wallace JL; McKnight GW; Donigi-Gale D; Shoupe TS; Granger DN
    J Lipid Mediat; 1993 Jun; 7(2):183-96. PubMed ID: 8400119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of cysteinyl-leukotrienes by human bronchial mucosa in chronic obstructive bronchitis.
    Luck W; Simmet T; Schmidt EW; Peskar BA
    Prog Clin Biol Res; 1989; 301():259-65. PubMed ID: 2508105
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukotrienes in mucosal damage and protection.
    Peskar BM
    J Physiol Pharmacol; 1991 Jun; 42(2):135-45. PubMed ID: 1782414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis.
    Tokumura A; Terao M; Okamoto M; Yoshida K; Tsukatani H
    Eur J Pharmacol; 1988 Apr; 148(3):353-60. PubMed ID: 3384001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung.
    Davidson D; Drafta D
    J Appl Physiol (1985); 1992 Sep; 73(3):955-61. PubMed ID: 1400062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of leukotrienes in hydrochloric acid-induced gastric lesions in rats.
    Osada T; Goto H; Tsukamoto Y; Nakazawa S; Sugiyama S; Ozawa T
    Dig Dis Sci; 1990 Feb; 35(2):186-92. PubMed ID: 2105876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release and effects of sulfidopeptide-leukotrienes in heart and vascular tissues.
    Simmet T; Lange K; Degitz K; Dembinska-Kiéc A; Hoppe U; Peskar BM; Peskar BA
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():261-7. PubMed ID: 2949553
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens.
    Coceani F; Bishai I; Lees J; Hynes N
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():480a-d. PubMed ID: 1825586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.